Doctors hail drug that spares bladder cancer patients ‘life-changing’ surgery
Durvalumab shows promising results in trial led by London-based Institute of Cancer ResearchDoctors are hailing a drug that spares bladder cancer patients “life-changing” surgery and stops tumours coming back.Bladder cancer is the ninth most common cancer in the world. Advanced or aggressive forms are often treated with surgery to remove the entire bladder, with patients left having to find alternative ways to pass urine for the rest of their life. Continue reading…
Durvalumab shows promising results in trial led by London-based Institute of Cancer ResearchDoctors are hailing a drug that spares bladder cancer patients “life-changing” surgery and stops tumours coming back.Bladder cancer is the ninth most common cancer in the world. Advanced or aggressive forms are often treated with surgery to remove the entire bladder, with patients…
Durvalumab shows promising results in trial led by London-based Institute of Cancer ResearchDoctors are hailing a drug that spares bladder cancer patients “life-changing” surgery and stops tumours coming back.Bladder cancer is the ninth most common cancer in the world. Advanced or aggressive forms are often treated with surgery to remove the entire bladder, with patients left having to find alternative ways to pass urine for the rest of their life. Continue reading…
The full story continues on The Guardian.
Story Sentry shows a short summary aggregated via RSS. The complete article — original photography, charts, and reporting — lives with the publisher.